EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail
暂无分享,去创建一个
M. Ressing | F. Claas | E. Wiertz | B. Griffin | A. Mulder | Fred Wang | D. van Leeuwen | A. M. Gram | Daphne van Leeuwen
[1] M. Carrington,et al. Erratum: Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2 (Journal of Clinical Investigation (2010) 120, 11 (4102-4110) DOI: 10.1172/JCI43998) , 2011 .
[2] M. Rowe,et al. The Epstein-Barr Virus-Encoded BILF1 Protein Modulates Immune Recognition of Endogenously Processed Antigen by Targeting Major Histocompatibility Complex Class I Molecules Trafficking on both the Exocytic and Endocytic Pathways , 2010, Journal of Virology.
[3] M. Carrington,et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. , 2010, The Journal of clinical investigation.
[4] R. Leurs,et al. The Epstein-Barr Virus-encoded G Protein-coupled Receptor BILF1 Hetero-oligomerizes with Human CXCR4, Scavenges Gαi Proteins, and Constitutively Impairs CXCR4 Functioning* , 2010, The Journal of Biological Chemistry.
[5] L. Moretta,et al. The Emerging Role of HLA-E-Restricted CD8+ T Lymphocytes in the Adaptive Immune Response to Pathogens and Tumors , 2010, Journal of biomedicine & biotechnology.
[6] E. Wiertz,et al. Herpesviruses and immunity: the art of evasion. , 2010, Veterinary microbiology.
[7] M. Bouvier,et al. MHC class I antigen presentation: learning from viral evasion strategies , 2009, Nature Reviews Immunology.
[8] E. Kremmer,et al. Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic Cycle , 2009, PLoS pathogens.
[9] Noam Stern-Ginossar,et al. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. , 2009, Cell host & microbe.
[10] E. Kremmer,et al. Specific Targeting of the EBV Lytic Phase Protein BNLF2a to the Transporter Associated with Antigen Processing Results in Impairment of HLA Class I-Restricted Antigen Presentation1 , 2009, The Journal of Immunology.
[11] M. Ressing,et al. The Epstein-Barr Virus G-Protein-Coupled Receptor Contributes to Immune Evasion by Targeting MHC Class I Molecules for Degradation , 2009, PLoS pathogens.
[12] Saskia Nijmeijer,et al. Viral hijacking of human receptors through heterodimerization. , 2008, Biochemical and biophysical research communications.
[13] Xiaoli Wang,et al. Viral and cellular MARCH ubiquitin ligases and cancer. , 2008, Seminars in cancer biology.
[14] M. Ressing,et al. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products. , 2008, Seminars in cancer biology.
[15] M. Rosenkilde,et al. Structure, function and physiological consequences of virally encoded chemokine seven transmembrane receptors , 2008, British journal of pharmacology.
[16] A. Marchese,et al. G protein-coupled receptor sorting to endosomes and lysosomes. , 2008, Annual review of pharmacology and toxicology.
[17] M. von Zastrow,et al. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. , 2008, Annual review of pharmacology and toxicology.
[18] M. Ressing,et al. The DNase of Gammaherpesviruses Impairs Recognition by Virus-Specific CD8+ T Cells through an Additional Host Shutoff Function , 2007, Journal of Virology.
[19] M. Ressing,et al. A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.
[20] A. Rickinson,et al. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. , 2007, Annual review of immunology.
[21] M. Ressing,et al. Host shutoff during productive Epstein–Barr virus infection is mediated by BGLF5 and may contribute to immune evasion , 2007, Proceedings of the National Academy of Sciences.
[22] T. Schwartz,et al. Molecular Pharmacological Phenotyping of EBI2 , 2006, Journal of Biological Chemistry.
[23] P. Lehner,et al. Lysine‐63‐linked ubiquitination is required for endolysosomal degradation of class I molecules , 2006, The EMBO journal.
[24] P. Sampaio,et al. Lack of Tyrosine 320 Impairs Spontaneous Endocytosis and Enhances Release of HLA-B27 Molecules , 2006, The Journal of Immunology.
[25] M. Rabelink,et al. A system for efficient generation of adenovirus protein IX‐producing helper cell lines , 2006, The journal of gene medicine.
[26] J. Kutok,et al. Spectrum of Epstein-Barr virus-associated diseases. , 2006, Annual review of pathology.
[27] M. Ressing,et al. Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection1 , 2005, The Journal of Immunology.
[28] A. Rickinson,et al. CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells , 2005, The Journal of experimental medicine.
[29] M. Rosenkilde,et al. Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor , 2005, Journal of Virology.
[30] R. Leurs,et al. The Epstein-Barr Virus BILF1 Gene Encodes a G Protein-Coupled Receptor That Inhibits Phosphorylation of RNA-Dependent Protein Kinase , 2005, Journal of Virology.
[31] Vladimir Brusic,et al. Virtual models of the HLA class I antigen processing pathway. , 2004, Methods.
[32] F. Carlotti,et al. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[33] M. Ressing,et al. Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation 1 , 2003, The Journal of Immunology.
[34] J. Bonifacino,et al. Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.
[35] A. Rickinson,et al. TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus. , 2003, Microbes and infection.
[36] P. Rivailler,et al. Complete Genomic Sequence of an Epstein-Barr Virus-Related Herpesvirus Naturally Infecting a New World Primate: a Defining Point in the Evolution of Oncogenic Lymphocryptoviruses , 2002, Journal of Virology.
[37] E. Wiertz,et al. Viral immune evasion: a masterpiece of evolution , 2002, Immunogenetics.
[38] M. Bonneville,et al. Asymptomatic deficiency in the peptide transporter associated to antigen processing (TAP) , 2002, Clinical and experimental immunology.
[39] P. Lehner,et al. Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101‐dependent degradation , 2002, The EMBO journal.
[40] P. Rivailler,et al. Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model , 2002, Journal of Virology.
[41] S. Akira,et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Virelizier,et al. Latently Infected Thp-1 Monocytes Receptor Gene Us28 Is Transcribed in Human Cytomegalovirus Chemokine , 2000 .
[43] R. Doms,et al. Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[44] J. Benovic,et al. Role of the Differentially Spliced Carboxyl Terminus in Thromboxane A2 Receptor Trafficking , 2001, The Journal of Biological Chemistry.
[45] J. Ramer,et al. An Epstein-Barr-related herpesvirus from marmoset lymphomas. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Nakanishi,et al. PICK1 Interacts with and Regulates PKC Phosphorylation of mGLUR7 , 2000, The Journal of Neuroscience.
[47] D. Ganem,et al. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[48] Jae U. Jung,et al. Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.
[49] J. Cohen,et al. Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells , 1999, Journal of Virology.
[50] P. A. Peterson,et al. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation. , 1998, Journal of immunology.
[51] T. Rapoport,et al. Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.
[52] N. Davis-Poynter,et al. Masters of deception: A review of herpesvirus immune evasion strategies , 1996, Immunology and cell biology.
[53] J. Neefjes,et al. Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surface , 1996, The Journal of cell biology.
[54] C. J. Beall,et al. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. , 1995, Biochemical and biophysical research communications.
[55] M J Clemens,et al. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. , 1993, Nucleic acids research.
[56] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[57] C. Barnstable,et al. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.
[58] I. Doxiadis,et al. Human monoclonal HLA antibodies reveal interspecies crossreactive swine MHC class I epitopes relevant for xenotransplantation. , 2010, Molecular immunology.
[59] E. Thiry,et al. The order Herpesvirales , 2008, Archives of Virology.
[60] R. Leurs,et al. HCMV-encoded G-protein-coupled receptors as constitutively active modulators of cellular signaling networks. , 2006, Trends in pharmacological sciences.
[61] H. Kung,et al. Retrotransposition and herpesvirus evolution , 2005, Virus Genes.
[62] M. Raftery,et al. Herpesvirus Homologues of Cellular Genes , 2004, Virus Genes.
[63] Antonio Alcami,et al. Viral mimicry of cytokines, chemokines and their receptors , 2003, Nature Reviews Immunology.
[64] R. Tampé,et al. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. , 1997, Blood.
[65] E. Kieff. Epstein-Barr virus and its replication , 1996 .